(株)メドレックスの貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4586/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2023/03/03日証協無担保76,400株0%0株0%228,630株+8.2%
2023/03/03日証協有担保1,148,700株-46.14%407,800株+48.89%551,000株-47.67%
2023/02/24日証協無担保0株-100%0株0%211,300株+4.49%
2023/02/24日証協有担保2,132,600株-58.39%273,900株-54.08%1,053,000株-36.97%
2023/02/17日証協無担保15,600株-15.22%0株0%202,214株-59.25%
2023/02/17日証協有担保5,125,100株+13.62%596,500株+221.04%1,670,502株-28.18%
2023/02/10日証協無担保18,400株-71.16%0株0%496,176株-32.84%
2023/02/10日証協有担保4,510,800株+0.67%185,800株-64.54%2,325,800株+88.38%
2023/02/03日証協無担保63,800株+187.39%0株0%738,800株-18.51%
2023/02/03日証協有担保4,480,600株-18.74%523,900株-46.73%1,234,600株-52.54%
2023/01/27日証協無担保22,200株0%0株0%906,590株+586.81%
2023/01/27日証協有担保5,513,900株+2618.89%983,500株+1173.96%2,601,304株+949.76%
2023/01/20日証協無担保0株0%0株0%132,000株+248.28%
2023/01/20日証協有担保202,800株-70.64%77,200株0%247,800株+740%
2023/01/13日証協無担保0株0%0株0%37,900株0%
2023/01/13日証協有担保690,700株+1251.66%0株0%29,500株+18.47%
2023/01/06日証協無担保0株0%0株0%37,900株-87.93%
2023/01/06日証協有担保51,100株-42.26%0株-100%24,900株-90.9%
2022/12/30日証協無担保0株0%0株0%314,055株+1541.09%
2022/12/30日証協有担保88,500株-54.55%12,500株0%273,500株+191.89%
2022/12/23日証協無担保0株0%0株0%19,137株+18.13%
2022/12/23日証協有担保194,700株+199.54%0株0%93,700株+235.84%
2022/12/16日証協無担保0株0%0株0%16,200株-89.38%
2022/12/16日証協有担保65,000株-95.81%0株-100%27,900株-93.36%
2022/12/09日証協無担保0株0%0株0%152,500株+1594.44%
2022/12/09日証協有担保1,552,000株+312.99%5,900株+18%420,400株+77.38%
2022/12/02日証協無担保0株0%0株0%9,000株+66.64%
2022/12/02日証協有担保375,800株+279.21%5,000株0%237,000株+182.48%
2022/11/18日証協無担保0株0%0株0%13,500株-50.91%
2022/11/18日証協有担保784,700株-2.21%3,100株+933.33%32,500株-50.23%
2022/11/11日証協無担保0株-100%0株0%27,499株+174.99%
2022/11/11日証協有担保802,400株+228.31%300株0%65,300株-29.71%
2022/11/04日証協無担保1,300株-97.67%0株0%10,000株+17.65%
2022/11/04日証協有担保244,400株+24.95%0株0%92,900株-35.62%
2022/10/28日証協無担保55,700株-77.59%0株0%8,500株-10.53%
2022/10/28日証協有担保195,600株-67.52%0株-100%144,300株-29.2%
2022/10/21日証協無担保248,500株+9840%0株0%9,500株-57.01%
2022/10/21日証協有担保602,300株-34.62%300株-98.31%203,800株-13.2%

※株式分割は考慮していませんのでご注意ください。

Page Top